Denmark rubber stamps Sanofi blockbuster for infants
Dupixent can now be administered to virtually all patients from cradle to grave.
Small children as young as 6 months can now be prescribed Sanofi and Regeneron’s best-selling drug Dupixent (dupilumab) for atopic eczema.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Dupixent becomes ninefold blockbuster
For subscribers
Sanofi presents positive mid-stage data for eczema drug
For subscribers
